142 related articles for article (PubMed ID: 4199964)
1. [Long-term treatment of arterial occlusive diseases using vasodilator agents].
Bartusch M; Mörl H; Ridha G; Preubb EG
Z Gesamte Inn Med; 1973 May; 28(9):Suppl 9:137-9. PubMed ID: 4199964
[No Abstract] [Full Text] [Related]
2. [Long-term drug therapy of chronic arterial occlusive diseases].
Hackel F; Ludewig R; Voigt H; Wiemers U
Z Gesamte Inn Med; 1973 May; 28(9):Suppl 9:140-1. PubMed ID: 4199965
[No Abstract] [Full Text] [Related]
3. [Use of vasodilator agents in arterial occlusive diseases].
Mörl H
Vasa; 1974; 3(3):287-92. PubMed ID: 4417244
[No Abstract] [Full Text] [Related]
4. Effect of vasodilator drugs in occlusive vascular disease.
Westling H
Scand J Clin Lab Invest Suppl; 1973; 128():207-9. PubMed ID: 4764582
[No Abstract] [Full Text] [Related]
5. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
Brugmans J; Jageneau A; Adriaensen H
Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
[No Abstract] [Full Text] [Related]
6. [Intra-arterial vasodilatative infusion and normal blood supply in peripheral angiopathy].
Bartusch M; Ridha G; Mörl H; Preuss EG
Angiologica; 1973; 10(1):24-30. PubMed ID: 4710547
[No Abstract] [Full Text] [Related]
7. [Hemodynamics in arterial insufficiency].
Lambert J
Acta Clin Belg Suppl; 1976; 9():1-245. PubMed ID: 1072336
[No Abstract] [Full Text] [Related]
8. [Peripheral blood flow velocity in arterial occlusive disease during i.v. long term therapy with vasoactive agents. Plethysmographic comparative study].
Heidrich H; Witt D; Witt E
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1750-2. PubMed ID: 347800
[No Abstract] [Full Text] [Related]
9. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
Racenberg J; Intaglietta M; Messmer K
Fortschr Med; 1982 Nov; 100(41):1926-30. PubMed ID: 7152426
[TBL] [Abstract][Full Text] [Related]
10. [Rheographic study of nicergolin in the circulation of the lower limbs in healthy and arteriopathic subjects].
Boismare F; Philippe JC; Leduc X
Therapie; 1974; 29(6):925-32. PubMed ID: 4618389
[No Abstract] [Full Text] [Related]
11. Thermography for studying nicotinyl alcohol tartrate.
Winsor T
Angiology; 1975 Feb; 26(2):225-32. PubMed ID: 1090219
[No Abstract] [Full Text] [Related]
12. [Clinical trial of fenoxedil in peripheral artery diseases].
Warembourg H; Thery C
Lille Med; 1976 Jan; 21(1 suppl 1):4-7. PubMed ID: 1256230
[No Abstract] [Full Text] [Related]
13. [Treatment of peripheral arterial diseases].
Mikita J
Orv Hetil; 2005 May; 146(22):1209-11. PubMed ID: 15997667
[No Abstract] [Full Text] [Related]
14. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
[No Abstract] [Full Text] [Related]
15. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
[No Abstract] [Full Text] [Related]
16. The effect of the nitrophenyl-dimethyl-dihydropyridine derivative nifedipine on intercoronary collateral circulation.
Kanazawa T; Suzuki N; Ino-oka E; Takahashi T; Mori A
Arzneimittelforschung; 1974 Sep; 24(9):1267-74. PubMed ID: 4479789
[No Abstract] [Full Text] [Related]
17. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
Schuster CJ; von Ungern-Sternberg AF
ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
[No Abstract] [Full Text] [Related]
18. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
[No Abstract] [Full Text] [Related]
19. [Physiopathology and therapy of obliterating arteriopathies].
Schettler G; Mörl H
Clin Ter; 1979 Jan; 88(1):3-19. PubMed ID: 436376
[No Abstract] [Full Text] [Related]
20. Substances with vasoactive effects mediated by the prostaglandin system.
Pallapies D; Peskar BA
Vasa Suppl; 1991; 33():75-6. PubMed ID: 1788770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
